Shareholding disclosure

Polar Capital LLP

Declared position

3.08%

Threshold

Crossed upwards

Timeline

Published

22.09.2018

Transaction

13.09.2018

Voting rights breakdown

Voting rights acquired3.08%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAI9J00014

Beneficial owner

Polar Capital LLP

Declared address

Polar Capital LLP, SW1E5JD/ London

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Polar Capital LLP

Newron Pharmaceuticals S.p.A.22.09.2018TAI9J00014

Disclosure summary

Polar Capital LLP disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 22.09.2018, at 3.08% of voting rights. Notice category: Single shareholder.

Disclosed position

3.08%

Voting rights acquired

Voting rights acquired3.08%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Polar Capital LLP disclosed a holding in Newron Pharmaceuticals S.p.A., published on 22.09.2018.

Publication date22.09.2018

Transaction date13.09.2018

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerPolar Capital LLP

Declared addressPolar Capital LLP, SW1E5JD/ London

CategorySingle shareholder

Voting rights acquired3.08%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAI9J00014

Source: SIX Exchange Regulation · Publication date: 22.09.2018

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open